

Eclipse Regenesis Information
Get Verified Emails For Eclipse Regenesis
Contact top employees from
Eclipse Regenesis
Summary
The first tissue regeneration therapy for Short Bowel Syndrome (SBS). SBS is a devastating condition where the small intestine is too short to absorb sufficient nutrients to sustain a patient. It resu...Show more
Organization Website | eclipseregenesis.com |
Social Links | |
Industries | |
Headquarters Location | 1440 O'Brien Drive, Menlo Park, California, 94025 US |
Employees Size | 1-10 employees |
Specialties | short bowel syndrome, medical device, tissue regeneration therapy |
Founded | 2017 |
Employees Turnover 4 quarter 2025
Number of employees by department
Total number all of employee turnover
Discover More
Length of Employment
Employee tenure at Eclipse Regenesis shows a diverse range of experience levels:
20% have been with the company for less than 1 year20% for 1–2 years20% for 3–4 years40% for 5–7 yearsDiscover More
Ex-employees positions
In Company
In New Company
Sign Up
Contact top employees from
Eclipse Regenesis
Ryan Helmuth
Head of Therapy Development, Clinical Affairs
Andrew Lantz
Head of Design
Anne Laure Thomas
Research And Development Engineer
Andre Bessette
Chief Executive Officer
Michael Seffren
Senior Research And Development Engineer
Companies Similar to Eclipse Regenesis
FAQ
Eclipse Regenesis operates in the Medtech industries. More details can be found on the official website: eclipseregenesis.com.
The headquarters of Eclipse Regenesis are located in Menlo Park, United States.
Eclipse Regenesis currently employs 1-10 people.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

